H. Lundbeck A Logo

H. Lundbeck A

Develops and commercializes innovative therapeutics for brain diseases globally.

HLUN | CO

Overview

Corporate Details

ISIN(s):
DK0061804697 (+5 more)
LEI:
5493006R4KC2OI5D3470
Country:
Denmark
Address:
Ottiliavej 9, 2500 Valby
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

H. Lundbeck A/S is a global pharmaceutical company dedicated exclusively to developing and commercializing innovative treatments for brain diseases. The company's core focus is on neuroscience, engaging in the full value chain of research, development, manufacturing, and sales of therapeutics for psychiatric and neurological disorders. Its portfolio addresses a variety of conditions, including depression, migraine, and rare epilepsies. With a mission to advance brain health, Lundbeck markets its specialized products in numerous countries worldwide, managing operations from initial research to patient delivery.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 14:51
Regulatory Filings
English 96.8 KB
2025-11-14 12:45
M&A Activity
English 25.3 KB
2025-11-14 12:45
Regulatory Filings
English 96.8 KB
2025-11-11 15:22
Regulatory Filings
English 116.4 KB
2025-11-11 15:22
Earnings Release
English 24.6 KB
2025-09-20 08:00
Regulatory Filings
English 146.2 KB
2025-09-20 08:00
Legal Proceedings Report
English 30.0 KB
2025-08-13 18:41
Interim / Quarterly Report
English 1.0 MB
2025-08-13 18:41
Earnings Release
English 32.1 KB
2025-08-13 18:35
Earnings Release
English 24.2 KB
2025-08-13 18:35
Earnings Release
English 129.5 KB
2025-02-21 13:27
Director's Dealing
English 124.1 KB
2025-02-21 13:27
Director's Dealing
English 29.9 KB
2025-02-05 16:40
Director's Dealing
English 134.1 KB
2025-02-05 16:40
Director's Dealing
English 96.6 KB

Automate Your Workflow. Get a real-time feed of all H. Lundbeck A filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for H. Lundbeck A

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for H. Lundbeck A via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BIO-FD&C CO.,LTD. Logo
Develops plant cell-derived active ingredients for food, drug, and cosmetic industries.
South Korea
251120
Biofrontera AG Logo
Biopharma firm specializing in photodynamic therapy for dermatological conditions like actinic keratosis.
Germany
B8F
Biofrontera Inc. Logo
Biopharma firm commercializing photodynamic therapy & antibiotics for skin conditions.
United States of America
BFRI
BioGaia Logo
Develops and commercializes clinically proven probiotics for digestive health across all life stages.
Sweden
BIOG
BIOGEN INC. Logo
Develops innovative therapies for complex neurological and neurodegenerative conditions.
United States of America
BIIB
Bio Green Med Solution, Inc. Logo
Develops cancer medicines and supplies fire safety equipment for global markets.
United States of America
BGMS
BIOHARVEST SCIENCES INC. Logo
Biotech platform that grows plant cells to produce active compounds for human wellness products.
United States of America
BHST
Biohaven Ltd. Logo
Clinical-stage biopharma developing drugs for neuroscience, immunology, and oncology.
United States of America
BHVN
BioInvent International Logo
Develops first-in-class immuno-modulatory antibodies for cancer therapy.
Sweden
BINV
BIOLIFE SOLUTIONS INC Logo
Develops bioproduction tools and services for the cell and gene therapy industry.
United States of America
BLFS

Talk to a Data Expert

Have a question? We'll get back to you promptly.